A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
AUTOR(ES)
Yin, Juan Juan
FONTE
National Academy of Sciences
RESUMO
Osteoblastic bone metastases are common in prostate and breast cancer patients, but mechanisms by which tumor cells stimulate new bone formation are unclear. We identified three breast cancer cell lines that cause osteoblastic metastases in a mouse model and secrete endothelin-1. Tumor-produced endothelin-1 stimulates new bone formation in vitro and osteoblastic metastases in vivo via the endothelin A receptor. Treatment with an orally active endothelin A receptor antagonist dramatically decreased bone metastases and tumor burden in mice inoculated with ZR-75-1 cells. Tumor-produced endothelin-1 may have a major role in the establishment of osteoblastic bone metastases, and endothelin A receptor blockade represents effective treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=196909Documentos Relacionados
- Endothelin-1 and osteoblastic metastasis
- Role of endothelin-1 in lung disease
- Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth.
- Multiple targets for endothelin-1 in human intestine.
- Endothelin-1 in idiopathic pulmonary fibrosis.
